MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...

Open Airways will host a  COPD Health Fair and complimentary Afternoon Tea on November 16th which “will offer free flu shots, ...

Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...

Medications for pulmonary embolism may decrease the size of blood clots, help dissolve them, or reduce the risk of recurrence. All of these medications carry the risk of bleeding. A pulmonary ...

Chronic Obstructive Pulmonary Disease (COPD) is a major health issue globally, primarily caused by smoking and environmental ...

Flaugh said there is no cure for COPD but there are different ways for people to improve their symptoms. “It is different ...

When most people hear the word hypertension, they think of high blood pressure. While not as common as high blood pressure, ...

Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Discover how moderate-to-vigorous physical activity can reduce exacerbations and corticosteroid use in COPD patients on dual ...

People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

Many outpatients with moderate to severe COPD had suboptimal peak inspiratory flow and had inappropriate devices for measured PIF.